Doctor profile · Federal record
Dr. Matthew Brier, MD
Neurology Physician (CMS: Neurology) · Saint Louis, MO
- NPI 1689194730
- Accepts Medicare
- MIPS 79.3 / 100 · 2023
- 9 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
4921 Parkview Pl, Div Neurology Multiple Sclerosis, 7Th Fl
Saint Louis, MO 631101032
(314) 362-3293
fax (314) 747-1345 - Mailing address
-
Po Box 7412011
Chicago, IL 606742011
Credentials & registration
- NPI registered
- June 2017 — 9 yrs on file
- Profile last updated
- April 15, 2025
- Year of graduation
- 2017 — 9 yrs since
- Specialty taxonomy
- 2084N0400X — NUCC code
- State license (1)
- Missouri #2020040167
- Medicaid
- MO #200057700
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1689194730. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
88
Distinct HCPCS
3
Medicare allowed
$8,978
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 60 | 14 | $78 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 17 | 15 | $170 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 11 | 11 | $126 |
In context: peer comparison
Among 66 peers in Saint Louis Neurology Physician, average services per provider: 431. This provider delivers 0.2× the peer median.Open Payments
Industry payments received
All-time total
$33,100
Transactions
30
Manufacturers
8
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Genzyme Corporation | 10 | $25,515.88 | |
| Biogen, INC. | 1 | $3,425.00 | |
| Roche Diagnostics International LTD | 1 | $3,300.00 | |
| Novartis Pharmaceuticals Corporation | 13 | $608.85 | |
| Tg Therapeutics, INC. | 1 | $116.01 | |
| Celgene Corporation | 2 | $94.39 | |
| Alexion Pharmaceuticals, INC. | 1 | $24.43 | |
| Banner Life Sciences, LLC | 1 | $15.02 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
267
Patients
0
Total drug cost
$1,317,286
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Enspryng (Satralizumab-Mwge) | Brand | 46 | 0 | $900,268 |
| Baclofen | Generic | 30 | 0 | $468 |
| Gabapentin | Generic | 28 | 0 | $1,326 |
| Dalfampridine ER (Dalfampridine) | Brand | 20 | 0 | $19,702 |
| Pregabalin | Generic | 19 | 0 | $4,126 |
| Copaxone (Glatiramer Acetate) | Brand | 18 | 0 | $131,927 |
| Duloxetine Hcl | Generic | 16 | 0 | $137 |
| Ampyra (Dalfampridine) | Brand | 12 | 0 | $50,157 |
| Cyclobenzaprine Hcl | Generic | 12 | 0 | $46 |
| Aubagio (Teriflunomide) | Brand | 11 | 0 | $111,057 |
Hospital affiliations
Frequently asked questions
What is Dr. Matthew Brier's medical specialty?
Dr. Matthew Brier practices Neurology Physician in Saint Louis, MO.
Where does Dr. Matthew Brier practice?
Dr. Matthew Brier practices at 4921 Parkview Pl, Saint Louis, MO 631101032. Office phone: 3143623293.
What is Dr. Matthew Brier's NPI?
Dr. Matthew Brier's National Provider Identifier (NPI) is 1689194730, issued by NPPES.
Does Dr. Matthew Brier accept Medicare assignment?
Yes. Dr. Matthew Brier accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Matthew Brier commonly perform?
Top Medicare-reported procedures in 2023: Subsequent hospital care with moderate levelof medical decision making (HCPCS 99232); Established patient office or other outpatient visit (HCPCS 99215); Established patient office or other outpatient visit (HCPCS 99214). Source: CMS Medicare Physician & Other Practitioners file.